CIBC World Markets’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.77M | Sell |
5,417
-451
| -8% | -$147K | 0.01% | 534 |
|
|
2025
Q1 | $1.58M | Buy |
5,868
+58
| +1% | +$15.7K | 0.01% | 554 |
|
|
2024
Q4 | $1.37M | Sell |
5,810
-1,561
| -21% | -$367K | 0.01% | 582 |
|
|
2024
Q3 | $2.03M | Buy |
7,371
+553
| +8% | +$152K | 0.01% | 521 |
|
|
2024
Q2 | $1.66M | Buy |
6,818
+1,680
| +33% | +$408K | 0.01% | 528 |
|
|
2024
Q1 | $768K | Buy |
5,138
+1,656
| +48% | +$247K | 0.01% | 675 |
|
|
2023
Q4 | $666K | Buy |
+3,482
| New | +$666K | ﹤0.01% | 630 |
|
|
2017
Q1 | – | Sell |
-210,000
| Closed | -$7.86M | – | 567 |
|
|
2016
Q4 | $7.86M | Buy |
+210,000
| New | +$7.86M | 0.08% | 168 |
|